ÂÜÀòÂÒÂ×

Yaron Daniely is a seasoned professional in the HealthTech and Life Sciences sectors, currently serving as a Board Observer at Lyfegen and holding investor and board member roles at Coltac Therapeutics Ltd. and caVos Biotherapeutics. Daniely is also the Chairperson at MetaSight Diagnostics and Nectin Therapeutics, and has been a General Partner at aMoon Fund since November 2019, contributing to global investments in health technologies. Previously, Daniely was the President & CEO of Yissum Research Development Company and co-founded Israel's Bio-MBA program at The College of Management Academic Studies. Daniely's academic credentials include a Ph.D. in Biochemistry from New York University and several post-doctoral studies, specializing in Skin Stem Cells and Cancer Biology.